Andra AP fonden lowered its holdings in Express Scripts Holding Company (NASDAQ:ESRX) by 10.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 88,900 shares of the company’s stock after selling 10,800 shares during the quarter. Andra AP fonden’s holdings in Express Scripts Holding were worth $5,675,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Park National Corp OH raised its stake in shares of Express Scripts Holding by 0.3% during the 2nd quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after acquiring an additional 11 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Express Scripts Holding by 0.3% during the 2nd quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after acquiring an additional 23 shares in the last quarter. Carroll Financial Associates Inc. raised its stake in shares of Express Scripts Holding by 1.0% during the 2nd quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock worth $203,000 after acquiring an additional 30 shares in the last quarter. CAPROCK Group Inc. raised its stake in shares of Express Scripts Holding by 0.9% during the 2nd quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after acquiring an additional 33 shares in the last quarter. Finally, Honkamp Krueger Financial Services Inc. raised its stake in shares of Express Scripts Holding by 0.8% during the 2nd quarter. Honkamp Krueger Financial Services Inc. now owns 4,762 shares of the company’s stock worth $304,000 after acquiring an additional 38 shares in the last quarter. Institutional investors and hedge funds own 88.71% of the company’s stock.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) opened at 62.65 on Friday. The stock has a 50 day moving average of $61.89 and a 200 day moving average of $63.23. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $77.50. The stock has a market capitalization of $36.18 billion, a P/E ratio of 10.87 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last announced its earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.57 EPS. Equities research analysts anticipate that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/09/16/andra-ap-fonden-sells-10800-shares-of-express-scripts-holding-company-esrx.html.

Several research analysts recently commented on ESRX shares. Cowen and Company reiterated an “outperform” rating and set a $83.00 price objective on shares of Express Scripts Holding in a research note on Friday, June 9th. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the stock a “buy” rating in a research note on Tuesday, August 29th. BidaskClub lowered shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Finally, Needham & Company LLC started coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They set a “hold” rating for the company. Four equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $70.24.

In other news, VP Everett Neville sold 1,163 shares of Express Scripts Holding stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total value of $71,501.24. Following the transaction, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Phyllis S. Anderson sold 578 shares of Express Scripts Holding stock in a transaction on Friday, September 8th. The shares were sold at an average price of $63.13, for a total transaction of $36,489.14. Following the completion of the transaction, the vice president now directly owns 10,530 shares in the company, valued at $664,758.90. The disclosure for this sale can be found here. Insiders sold a total of 5,641 shares of company stock worth $357,317 over the last ninety days. Corporate insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.